Is HIV up or down today?
HIV is up 0.46% today, last at 219.92. This stock moved +0.46% versus the prior close.
HIV · HIV
HIV (HIV) is trading at 219.92, up 0.46% on the session. HIV sits at the 50% mark of its 52-week range.
Leading the coverage: “New HIV and Breast Cancer Wins Might Change The Case For Investing In Gilead Sciences (GILD) - simplywall.st” (Google News Company, 11d ago). HIV is +3.65% since story.
HIV trades on a trailing P/E of 19.7.
Analyst firms are mostly reiterating — no strong directional shift lately.
HIV is up 0.46% today, last at 219.92. This stock moved +0.46% versus the prior close.
Leading the coverage: “New HIV and Breast Cancer Wins Might Change The Case For Investing In Gilead Sciences (GILD) - simplywall.st” (Google News Company, 11d ago). HIV is +3.65% since story. Dominant story: GSK's Specialty Medicines Drive Growth Amid Looming HIV Patent Cliff - Zacks Investment Research (1 source, bullish) RSI unavailable Price sits at 50% of its 52-week range Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Historical price chart unavailable
Live quote in the header is real, but OHLC history could not be loaded from Yahoo Finance or fallback providers. Charts use Yahoo when configured correctly — check server logs for provider errors.
GSK's Specialty Medicines Drive Growth Amid Looming HIV Patent Cliff - Zacks Investment Research
Grindr to pay £26m to settle claims it allegedly shared users' HIV status - Yahoo! Finance Canada
Shionogi's Earnings Likely to Be Driven by HIV Royalties -- Market Talk - Moomoo
Gilead Sciences stock holds near highs as CEO share sale and HIV growth shape outlook - ad-hoc-news.de
New HIV and Breast Cancer Wins Might Change The Case For Investing In Gilead Sciences (GILD) - simplywall.st